Cargando…

From bench to bedside: the history and progress of CAR T cell therapy

Chimeric antigen receptor (CAR) T cell therapy represents a major breakthrough in cancer care since the approval of tisagenlecleucel by the Food and Drug Administration in 2017 for the treatment of pediatric and young adult patients with relapsed or refractory acute lymphocytic leukemia. As of April...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitra, Aroshi, Barua, Amrita, Huang, Luping, Ganguly, Siddhartha, Feng, Qin, He, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225594/ https://www.ncbi.nlm.nih.gov/pubmed/37256141 http://dx.doi.org/10.3389/fimmu.2023.1188049

Ejemplares similares

CAR-T Cell Therapy: From the Bench to the Bedside
por: Golubovskaya, Vita
Publicado: (2017)

The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with snRNP biogenesis machinery
por: Feng, Qin, et al.
Publicado: (2023)

CAR-T cell therapy in ovarian cancer: from the bench to the bedside
por: Zhu, Xinxin, et al.
Publicado: (2017)

CXCR2: From Bench to Bedside
por: Stadtmann, Anika, et al.
Publicado: (2012)

CAR-NK cells for cancer immunotherapy: from bench to bedside
por: Zhang, Leisheng, et al.
Publicado: (2022)

CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside
por: Zhang, Qi, et al.
Publicado: (2016)

Bench, Bedside, Toolbox: T-Cells Deliver on Every Level
por: Laugel, Bruno
Publicado: (2014)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
por: Tristán-Manzano, María, et al.
Publicado: (2020)

Investigating population-level immunosenescence: From bench to bedside
por: Cunha, Lucas Leite, et al.
Publicado: (2022)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
por: Wang, Ya-Tao, et al.
Publicado: (2022)

Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
por: Alfaleh, Mohamed A., et al.
Publicado: (2020)

Non-coding RNAs in Rheumatoid Arthritis: From Bench to Bedside
por: Wang, Jinghua, et al.
Publicado: (2020)

Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside
por: Ferreira, Valerie, et al.
Publicado: (2014)

Insights into the Role of Helicobacter pylori Infection in Preeclampsia: From the Bench to the Bedside
por: Tersigni, Chiara, et al.
Publicado: (2014)

Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside
por: Chae, Wook-Jin, et al.
Publicado: (2018)

Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside
por: Di Napoli, Mario, et al.
Publicado: (2018)

Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back
por: Chentoufi, Aziz A., et al.
Publicado: (2022)

The paradoxical role of MDSCs in inflammatory bowel diseases: From bench to bedside
por: Zhao, Fan, et al.
Publicado: (2022)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside
por: Shamshiripour, Parisa, et al.
Publicado: (2022)

Circular RNAs Involve in Immunity of Digestive Cancers From Bench to Bedside: A Review
por: Chen, Chunyue, et al.
Publicado: (2022)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
por: Valkenburg, Sophie A., et al.
Publicado: (2018)

CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018)

Cystic Diseases of the Kidneys: From Bench to Bedside
por: Raina, Rupesh, et al.
Publicado: (2023)

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
por: Liu, Taoming, et al.
Publicado: (2020)

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Mania in Wolfram’s Disease: From Bedside to Bench
por: Chatterjee, Seshadri Sekhar, et al.
Publicado: (2017)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
por: Goyvaerts, Cleo, et al.
Publicado: (2018)

Glucocorticoid therapy in respiratory illness: bench to bedside
por: Amratia, Dhruv Atool, et al.
Publicado: (2022)

Bench-to-bedside review: A brief history of clinical acid–base
por: Story, David A
Publicado: (2004)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

What we learned from bench to bedside with the neuroblastoma targeting CD171-specific CAR
por: Künkele, A, et al.
Publicado: (2015)

Hyperbaric oxygen therapy for traumatic brain injury: bench-to-bedside
por: Hu, Qin, et al.
Publicado: (2016)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v1an3bclkl7873l6pdsage0obn